ESR1 and triple-negative breast carcinoma: In breast cancer molecular subtypes, triple-negative breast cancer (TNBC) carrying the worst prognosis is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2].